The Board remands the claims for service connection for small cell neuroendocrine carcinoma of the base of the tongue, right brachial-plexus injury, and right upper extremity peripheral neuropathy due to a need for additional medical evidence.
The deciding factor: Remand is necessary to obtain an adequate medical examination and opinion regarding the etiology of the Veteran's claimed conditions in relation to his conceded toxic exposure risk activities (TERA).
- Claimed conditions
- small cell neuroendocrine carcinoma of the base of the tongue, right brachial-plexus injury, to include as secondary to exposure, right upper extremity peripheral neuropathy, to include as secondary to exposure
- How they argued it
- Direct service connection
- Exposure basis
- Gulf War
- Rating assigned
- None in this decision
- Decision date
- June 26, 2025
- Citation
- A25055724
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for segmental colitis associated with diverticulosis, small bowel obstruction, to include small bowel perforation, status post left hemicolectomy, Hartman's pouch and ileostomy (bowel condition), as well as right and left upper and lower extremity peripheral neuropathy.
- Partly granted
The Board granted a 30 percent rating for asthma but denied all other claims, including service connection for various conditions and a compensable rating for scars between the scapulae.
- Partly granted
The Board granted initial ratings of 70 percent for right upper extremity peripheral neuropathy, 60 percent for left upper extremity peripheral neuropathy, and 30 percent each for right and left lower extremity peripheral neuropathy (femoral and sciatic nerves), while denying an increased rating for allergic rhinitis and granting a 10 percent rating for chloracne of the face, arms, and back prior to September 27, 2018.
- Denied
The Board denied higher ratings for the service-connected peripheral neuropathy of the upper and lower extremities both prior to and from May 25, 1999.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.